Jubilant Life Sciences reports net loss of Rs 101 crore in Q4 consolidated

18 May 2019 Evaluate

Jubilant Life Sciences has reported results for the fourth quarter and year ended March 31, 2019. 

The company has reported a fall of 91.39% in its net profit at Rs 7.44 crore for the quarter ended March 31, 2019 as compared to Rs 86.39 crore for the same quarter in the previous year. Total income of the company decreased by 10.53% at Rs 869.95 crore for quarter under review as compared to Rs 972.32 crore for the quarter ended March 31, 2018.

On consolidated basis, the company has reported a net loss of Rs 100.65 crore for the quarter ended March 31, 2019 against net profit of Rs 152.40 crore for the corresponding quarter in the FY18. However, total consolidated income of the company rose marginally by 4.58% at Rs 2,379.00 crore for quarter under review as compared to Rs 2,274.87 crore for the same quarter ended previous year.

For the year ended March 31, 2019, the company has posted a fall of 44.18% in its net profit at Rs 147.06 crore as compared to Rs 263.44 crore for the previous year. However, total income of company increased marginally by 3.76% at Rs 3,516.61 crore for year under review as compared to Rs 3,389.22 crore for year ended March 31, 2018.

For the year ended March 31, 2019, on the consolidated basis, the company has posted fall of 9.05% in its net profit at Rs 577.01 crore as compared to Rs 634.42 crore for the previous year. However, total income of company increased by 20.38% at Rs 9,146.56 crore for year under review as compared to Rs 7,597.84 crore for year ended March 31, 2018.

Jubilant Pharmova Share Price

669.60 -32.05 (-4.57%)
19-Apr-2024 13:16 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1514.50
Dr. Reddys Lab 5906.10
Cipla 1349.15
Zydus Lifesciences 917.90
Lupin 1547.30
View more..
© 2024 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt.Ltd.